(Q43416668)

23 November 2017

title

Clinical Pharmacodynamic Studies with Cilazapril and a Combination of Cilazapril and Propranolol (English)

1 reference

10.2165/00003495-199100411-00004

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199100411-00004

5 November 2022

1 reference

K. A. Erb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712266

5 November 2022

J. Essig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712266

5 November 2022

K. Breithaupt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712266

5 November 2022

G. G. Belz

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712266

5 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712266

5 November 2022

publication date

1 January 1991

1 reference

23 November 2017

1 reference

23 November 2017

volume

41 Suppl 1

1 reference

23 November 2017

page(s)

11-17

1 reference

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

23 November 2017

cites work

1 reference

12 December 2020

Characterization of angiotensin converting enzyme by [3H]captopril binding

1 reference

12 December 2020

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

1 reference

12 December 2020

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers

1 reference

12 December 2020

Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex

1 reference

12 December 2020

Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

12 December 2020

A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.

1 reference

12 December 2020

Duration of Action and Short-Term Hormonal Responses to Enalapril (MK 421) in Normal Subjects

1 reference

12 December 2020

Enzymes of the Renin-Angiotensin System and their Inhibitors

1 reference

12 December 2020

Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases

1 reference

12 December 2020

Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension

1 reference

12 December 2020

Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots

1 reference

12 December 2020

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

12 December 2020

Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs

1 reference

12 December 2020

10.2165/00003495-199100411-00004

Identifiers

DOI

0 references

Dimensions Publication ID

1051884940

0 references

1 reference